Schedule 13D ownership disclosure
CELLULAR BIOMEDICINE GROUP I
Security class unavailable · CUSIP: 15117P102
Event date: 2018-02-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-045006
- Form type
- SC 13D
- Filer
- Cellular Biomedicine Group, Inc.
- CIK
- CIK 1378624
- Filed
- Feb 14, 2018
- Reporting period
- Feb 05, 2018
- Description
- Schedule 13D beneficial ownership